Alan D. Sobel is Director of Cytosorbents Corp. Currently has a direct ownership of 145,757 shares of CTSO, which is worth approximately $182,196. The most recent transaction as insider was on Feb 24, 2025, when has been sold 21,950 shares (Common Stock) at a price of $1.13 per share, resulting in proceeds of $24,803. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 146K
0% 3M change
43.1% 12M change
Total Value Held $182,196

Alan D. Sobel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2025
BUY
Exercise of out-of-the-money derivative securities
$24,803 $1.13 p/Share
21,950 Added 13.09%
145,757 Common Stock
Jan 17 2025
BUY
Exercise of in-the-money or at-the-money derivatives securities
$21,950 $1.0 p/Share
21,950 Added 15.06%
123,807 Common Stock
Dec 13 2023
BUY
Open market or private purchase
$30,000 $1.33 p/Share
22,557 Added 18.13%
101,857 Common Stock
Feb 27 2023
BUY
Bona fide gift
-
2,000 Added 2.4%
81,300 Common Stock
May 11 2022
BUY
Open market or private purchase
$20,100 $2.01 p/Share
10,000 Added 11.2%
79,300 Common Stock
ADS

Alan D. Sobel

Director
Princeton, NJ

Track Institutional and Insider Activities on CTSO

Follow Cytosorbents Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTSO shares.

Notify only if

Insider Trading

Get notified when an Cytosorbents Corp insider buys or sells CTSO shares.

Notify only if

News

Receive news related to Cytosorbents Corp

Track Activities on CTSO